According to the conference call of the earnings release, BG-12 is supposed to be next month. Does anyone have a specific date on this? The stock SHOULD take off on the news.
Sentiment: Strong Buy
this bg-12 is gonna be a flop-just like everything else biogen has.exceept,of course,tysabri.but they got screwed by offering to high of a royalties.instead,they should of bought elan with all their pioneering researches,staff and investments.
Kaiser said they won't pick up Tecfidera for maybe 2 years!! They say it's too experimental. I'm really bummed! I hate injections! :((
Tell me what else is going to flop so that I can buy it.